Published in Aliment Pharmacol Ther on February 01, 2005
Anti-ganglioside antibodies in children with coeliac disease: correlation with gluten-free diet and neurological complications. Aliment Pharmacol Ther (2004) 2.18
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet (2001) 3.28
Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology (1998) 2.68
Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med (2000) 2.40
Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis (2006) 1.85
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther (2009) 1.83
Parkinson disease: the enteric nervous system spills its guts. Neurology (2011) 1.81
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
Prevalence of silent coeliac disease in atopics. Dig Liver Dis (2000) 1.48
New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.45
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin. Dig Liver Dis (2001) 1.44
IgA antibodies to endomysium, gliadin, and reticulin in silent coeliac disease. Lancet (1992) 1.40
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol (1994) 1.38
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet (1990) 1.30
Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut (1985) 1.28
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol (1985) 1.23
Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil (2006) 1.23
HCV and autoimmunity. Curr Pharm Des (2008) 1.22
Subclinical celiac sprue. Increasing occurrence and clues to its diagnosis. J Clin Gastroenterol (1993) 1.20
Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil (2008) 1.20
Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology (2001) 1.17
Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? Gastroenterology (1999) 1.16
Can antigliadin antibody detect symptomless coeliac disease in children with short stature? Lancet (1985) 1.14
Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology (1993) 1.13
Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol (2001) 1.12
Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol (1999) 1.07
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis. Br J Cancer (2013) 1.05
Review article: autoimmune hepatitis -- current management and challenges. Aliment Pharmacol Ther (2013) 1.05
Serological screening for coeliac disease in vitiligo and alopecia areata. Br J Dermatol (1997) 1.03
Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol (2002) 1.02
Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations. Br J Pharmacol (2000) 1.02
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther (2005) 1.00
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol (2006) 1.00
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine. Gastroenterology (1999) 0.99
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol (2004) 0.94
[Chronic active hepatitis with antibodies against liver and kidney microsomes]. Med Chir Dig (1980) 0.94
Fos protein expression in the nucleus of the solitary tract in response to intestinal nutrients in awake rats. Brain Res (1994) 0.93
Autoimmune enteropathy and rheumatoid arthritis: a new association in the field of autoimmunity. Dig Liver Dis (2006) 0.92
Relationship between serum C3 levels and traditional risk factors for myocardial infarction. Acta Cardiol (1998) 0.91
Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Gut (1992) 0.90
Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients. Neurogastroenterol Motil (2012) 0.90
Gliadin immune reactivity is associated with overt and latent enteropathy in relatives of celiac patients. Gastroenterology (1992) 0.90
Tachykinin-dependent and -independent components of peristalsis in the guinea pig isolated distal colon. Gastroenterology (2001) 0.89
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. Neurogastroenterol Motil (2012) 0.89
Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am J Gastroenterol (2004) 0.89
Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction. Transplant Proc (2010) 0.89
Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus. Dig Liver Dis (2005) 0.89
Upper gastrointestinal bleeding due to duodenal metastasis from primary lung carcinoma. Dig Liver Dis (2002) 0.89
Antigliadin and antireticulin antibodies in coeliac disease and at onset of diabetes in children. Lancet (1987) 0.88
Coeliac disease in patients with autoimmune thyroiditis. Digestion (2001) 0.88
Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease. Neurosci Lett (2009) 0.87
R1 reticulin antibodies: markers of celiac disease in children on a normal diet and on gluten challenge. J Pediatr Gastroenterol Nutr (1984) 0.87
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin. Aliment Pharmacol Ther (2005) 0.87
Gliadin antibodies in coeliac disease. Lancet (1983) 0.86
Prevalence and characteristics of coeliac disease in type 1 diabetes mellitus. Acta Paediatr Scand (1987) 0.86
Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse. Gut (2003) 0.86
What will be the adult height of coeliac patients? Eur J Pediatr (1991) 0.86
Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection. Aliment Pharmacol Ther (2000) 0.86
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. Urology (2004) 0.86
Calcitonin gene-related peptide neurons innervating the canine digestive system. Regul Pept (1992) 0.86
Nitrergic and purinergic mechanisms evoke inhibitory neuromuscular transmission in the human small intestine. Neurogastroenterol Motil (2013) 0.85
Observations on a vestigial organ: a potential surrogate for enteric neuromesenchymal disease. Neurogastroenterol Motil (2008) 0.85
Nitric oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells. Gastroenterology (1995) 0.85
Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction. Hepatogastroenterology (1992) 0.85
Postinfectious gastroparesis related to autonomic failure: a case report. Neurogastroenterol Motil (2006) 0.84
Quantitation of cellular components of the enteric nervous system in the normal human gastrointestinal tract--report on behalf of the Gastro 2009 International Working Group. Neurogastroenterol Motil (2010) 0.84
Myenteric neuronal loss in rats with experimental colitis: role of tissue transglutaminase-induced apoptosis. Dig Liver Dis (2008) 0.84
Enteric neuropathy evoked by repeated cisplatin in the rat. Neurogastroenterol Motil (2011) 0.84
Demonstration of peptide-specific and cross-reactive epitopes in proteins reacting with antimitochondrial antibodies of primary biliary cirrhosis. J Hepatol (1992) 0.84
Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis. Dig Liver Dis (2001) 0.84
NK1 receptor expression in the interstitial cells of Cajal and neurons and tachykinins distribution in rat ileum during development. J Comp Neurol (1997) 0.84
Antibodies to gliadin in adult coeliac disease and dermatitis herpetiformis. Digestion (1984) 0.83
Clinical use of manometry for the diagnosis of intestinal motor abnormalities. Dig Liver Dis (2001) 0.83
HLA and enteric antineuronal antibodies in patients with achalasia. Neurogastroenterol Motil (2006) 0.83
Primary non-Hodgkin's T-cell lymphoma of the esophagus. A case with peculiar endoscopic ultrasonographic pattern. Dig Dis Sci (1990) 0.83
Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders. Neurogastroenterol Motil (2011) 0.83
A histological and immunohistochemical study of neuropeptide containing somatic nerves in the levator ani muscle of women with genitourinary prolapse. Acta Obstet Gynecol Scand (1999) 0.83
Unsuccessful octreotide treatment of the watermelon stomach. J Clin Gastroenterol (1998) 0.82
Identification of the autoantigen of celiac disease. Ann N Y Acad Sci (1998) 0.82
Anti-actin antibodies: a new test for an old problem. J Immunol Methods (1990) 0.82
Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptoms. Dig Liver Dis (2003) 0.82
Antibodies to dietary antigens in coeliac disease. Scand J Gastroenterol (1986) 0.82
Anti-ganglioside antibodies in coeliac disease with neurological disorders. Dig Liver Dis (2006) 0.82
Tachykinin NK(1)receptor-mediated inhibitory responses in the guinea-pig small intestine. Neuropeptides (1999) 0.82
Constipation: a common problem in patients with neurological abnormalities. Ital J Gastroenterol Hepatol (1998) 0.81
Monoclonal antibody to VIP: production, characterization, immunoneutralizing activity, and usefulness in cytochemical staining. Hybridoma (1996) 0.81
Splanchnic haemodynamics in patients with coeliac disease: effects of a gluten-free diet. Dig Liver Dis (2003) 0.81
Involvement of endogenous tachykinins and CGRP in the motor responses produced by capsaicin in the guinea-pig common bile duct. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.80